InspireMD, Inc. (NSPR) Total liabilities 2016–2025
InspireMD, Inc. (NSPR) total liabilities at each fiscal year-end, per SEC filings.
$14.2MFY2025 · since FY2016: $5.4M → $14.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.2M | +32.5% |
| FY2024 | $10.7M | +31.7% |
| FY2023 | $8.1M | +12.1% |
| FY2022 | $7.3M | +17.5% |
| FY2021 | $6.2M | +10.1% |
| FY2020 | $5.6M | +24.8% |
| FY2019 | $4.5M | +27.6% |
| FY2018 | $3.5M | +13.5% |
| FY2017 | $3.1M | -42.1% |
| FY2016 | $5.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NSPR financial trends
NSPR RevenueNSPR Net incomeNSPR Net marginNSPR Gross profitNSPR Gross marginNSPR Operating incomeNSPR Operating marginNSPR Operating cash flowNSPR Free cash flowNSPR Capital expendituresNSPR Return on equityNSPR Stock buybacksNSPR Dividends paidNSPR Total assetsNSPR Shareholders’ equityNSPR overview →